JP2016172781A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016172781A5 JP2016172781A5 JP2016136149A JP2016136149A JP2016172781A5 JP 2016172781 A5 JP2016172781 A5 JP 2016172781A5 JP 2016136149 A JP2016136149 A JP 2016136149A JP 2016136149 A JP2016136149 A JP 2016136149A JP 2016172781 A5 JP2016172781 A5 JP 2016172781A5
- Authority
- JP
- Japan
- Prior art keywords
- revascularization
- composition
- hours
- subject
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36313310P | 2010-07-09 | 2010-07-09 | |
| US36312910P | 2010-07-09 | 2010-07-09 | |
| US61/363,129 | 2010-07-09 | ||
| US61/363,133 | 2010-07-09 | ||
| US41265510P | 2010-11-11 | 2010-11-11 | |
| US61/412,655 | 2010-11-11 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013518868A Division JP6319738B2 (ja) | 2010-07-09 | 2011-07-08 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019000305A Division JP2019052188A (ja) | 2010-07-09 | 2019-01-04 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016172781A JP2016172781A (ja) | 2016-09-29 |
| JP2016172781A5 true JP2016172781A5 (cg-RX-API-DMAC7.html) | 2017-03-16 |
Family
ID=45441572
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013518868A Active JP6319738B2 (ja) | 2010-07-09 | 2011-07-08 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
| JP2016136149A Pending JP2016172781A (ja) | 2010-07-09 | 2016-07-08 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
| JP2019000305A Pending JP2019052188A (ja) | 2010-07-09 | 2019-01-04 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
| JP2020080135A Pending JP2020114880A (ja) | 2010-07-09 | 2020-04-30 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
| JP2021181839A Pending JP2022012924A (ja) | 2010-07-09 | 2021-11-08 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013518868A Active JP6319738B2 (ja) | 2010-07-09 | 2011-07-08 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019000305A Pending JP2019052188A (ja) | 2010-07-09 | 2019-01-04 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
| JP2020080135A Pending JP2020114880A (ja) | 2010-07-09 | 2020-04-30 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
| JP2021181839A Pending JP2022012924A (ja) | 2010-07-09 | 2021-11-08 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9345738B2 (cg-RX-API-DMAC7.html) |
| EP (3) | EP4285994A3 (cg-RX-API-DMAC7.html) |
| JP (5) | JP6319738B2 (cg-RX-API-DMAC7.html) |
| CN (4) | CN103249423A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2804404C (cg-RX-API-DMAC7.html) |
| HK (1) | HK1249428A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012006569A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2858550A1 (en) * | 2011-12-09 | 2013-06-13 | Stealth Peptides International, Inc. | Aromatic-cationic peptides and uses of same |
| HK1204988A1 (en) * | 2012-02-22 | 2015-12-11 | Stealth Peptides International, Inc. | Methods and compositions for preventing or treating ophthalmic conditions |
| CA2869080C (en) * | 2012-03-30 | 2020-09-01 | Stealth Peptides International, Inc. | Methods and compositions for the prevention and treatment neuropathy |
| EP3586864A1 (en) * | 2013-05-14 | 2020-01-01 | Stealth Biotherapeutics Corp | Methods for the prevention or treatment of left ventricle remodeling |
| CA2916492A1 (en) | 2013-06-27 | 2014-12-31 | Stealth Biotherapeutics Corp | Peptide therapeutics and methods for using same |
| US11724030B2 (en) * | 2018-09-21 | 2023-08-15 | Corflow Therapeutics Ag | Method and apparatus for diagnosis and treatment of microvascular dysfunction |
| US10870678B2 (en) | 2016-04-11 | 2020-12-22 | Arcuate Therapeutics, Inc. | Chiral peptides |
| US11034724B2 (en) | 2017-04-05 | 2021-06-15 | Stealth Biotherapeutics Corp. | Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH2 |
| AU2018336787B2 (en) | 2017-09-19 | 2024-05-30 | Corflow Therapeutics Ag | Intracoronary characterization of microvascular obstruction (MVO) and myocardial infarction |
| IL305687B2 (en) * | 2017-12-15 | 2024-12-01 | Stealth Biotherapeutics Inc | Mitochondria-targeting peptides |
| US11795196B2 (en) | 2017-12-15 | 2023-10-24 | Stealth Biotherapeutics Inc. | Mitochondria-targeting peptides |
| US10676506B2 (en) | 2018-01-26 | 2020-06-09 | Stealth Biotherapeutics Corp. | Crystalline bis- and tris-hydrochloride salt of elamipretide |
| CN113544138B (zh) * | 2018-12-18 | 2024-10-29 | 隐形生物治疗公司 | 线粒体靶向肽 |
| WO2020131283A1 (en) * | 2018-12-18 | 2020-06-25 | Stealth Biotherapeutics Corp. | Analogs that target mitochondrial diseases |
| JPWO2020189593A1 (cg-RX-API-DMAC7.html) | 2019-03-20 | 2020-09-24 | ||
| RU2711414C1 (ru) * | 2019-03-27 | 2020-01-17 | Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН) | Способ прогнозирования асимптомного повреждения вещества головного мозга при ангиореконструктивных операциях на сонных артериях |
| JP7638265B2 (ja) | 2019-07-24 | 2025-03-03 | ステルス バイオセラピューティクス インコーポレイテッド | 神経変性疾患の治療におけるペプチド模倣化合物（ｒ）－２－アミノ－ｎ－（（ｓ）－ｌ－（（（ｓ）－５－アミノ－ｌ－（３－ベンジル－１，２，４－オキサジアゾール－５－イル）ペンチル）アミノ）－３－（４－ヒドロキシ－２，６－ジメチルフェニル）－ｉ－オキソプロパン－２－イル）－５－グアニジノペンタンアミド |
| EP4792852A2 (en) | 2020-05-22 | 2026-08-19 | CorFlow Therapeutics AG | Controlled flow infusion microvascular dysfunction diagnostic and therapy |
| JP7533970B2 (ja) * | 2022-01-31 | 2024-08-14 | 株式会社ニューギン | 遊技機 |
| JP7478453B2 (ja) * | 2022-01-31 | 2024-05-07 | 株式会社ニューギン | 遊技機 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5182106A (en) * | 1986-05-15 | 1993-01-26 | Emory University | Method for treating hypothermia |
| US5858784A (en) | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
| JPH05301868A (ja) | 1992-04-23 | 1993-11-16 | Mitsui Toatsu Chem Inc | 虚血性心疾患治療剤 |
| US5674534A (en) | 1992-06-11 | 1997-10-07 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
| US5716644A (en) | 1992-06-11 | 1998-02-10 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
| US5989463A (en) | 1997-09-24 | 1999-11-23 | Alkermes Controlled Therapeutics, Inc. | Methods for fabricating polymer-based controlled release devices |
| US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
| EP1526140B1 (en) * | 2002-08-01 | 2008-11-05 | Astellas Pharma Inc. | Potassium-dependent sodium-calcium exchanger |
| SI2656854T1 (sl) * | 2003-02-04 | 2015-09-30 | Cornell Research Foundation, Inc. | Uporabe aromatsko-kationskega peptida |
| CA3024434A1 (en) * | 2004-01-23 | 2005-08-11 | Cornell Research Foundation, Inc. | Methods for reducing oxidative damage |
| EP3725324A1 (en) * | 2005-09-16 | 2020-10-21 | Cornell Research Foundation, Inc. | Aromatic-cationic peptide for use in a method for reducing cd36 expression |
| EP2519249A4 (en) * | 2009-12-31 | 2013-06-26 | Stealth Peptides Int Inc | METHOD FOR CARRYING OUT A CORONARY ARTERY BYPASS PROCEDURE |
| US20130195837A1 (en) * | 2009-12-31 | 2013-08-01 | Stealth Peptides International, Inc. | Methods for the prevention or treatment of vessel occlusion injury |
| EP2808029A3 (en) * | 2010-03-15 | 2015-04-01 | Stealth Peptides International, Inc. | Combination therapies using cyclosporine and aromatic cationic peptides |
-
2011
- 2011-07-08 CN CN2011800429365A patent/CN103249423A/zh active Pending
- 2011-07-08 CN CN201610616831.0A patent/CN106620645A/zh active Pending
- 2011-07-08 EP EP23185558.6A patent/EP4285994A3/en not_active Withdrawn
- 2011-07-08 JP JP2013518868A patent/JP6319738B2/ja active Active
- 2011-07-08 EP EP11804436.1A patent/EP2590664B1/en active Active
- 2011-07-08 US US13/808,027 patent/US9345738B2/en active Active
- 2011-07-08 EP EP19157391.4A patent/EP3539554A1/en not_active Withdrawn
- 2011-07-08 CA CA2804404A patent/CA2804404C/en active Active
- 2011-07-08 CN CN201710574500.XA patent/CN107569675A/zh active Pending
- 2011-07-08 CN CN201510122649.5A patent/CN105879008A/zh not_active Withdrawn
- 2011-07-08 WO PCT/US2011/043424 patent/WO2012006569A1/en not_active Ceased
-
2016
- 2016-05-18 US US15/158,005 patent/US10322159B2/en active Active
- 2016-07-08 JP JP2016136149A patent/JP2016172781A/ja active Pending
-
2018
- 2018-07-12 HK HK18109055.3A patent/HK1249428A1/zh unknown
-
2019
- 2019-01-04 JP JP2019000305A patent/JP2019052188A/ja active Pending
-
2020
- 2020-04-30 JP JP2020080135A patent/JP2020114880A/ja active Pending
-
2021
- 2021-11-08 JP JP2021181839A patent/JP2022012924A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013531682A5 (cg-RX-API-DMAC7.html) | ||
| JP2017165772A5 (cg-RX-API-DMAC7.html) | ||
| JP2013516425A5 (cg-RX-API-DMAC7.html) | ||
| Baek et al. | Effective mechanical thrombectomy in a patient with hyperacute ischemic stroke associated with cardiac myxoma | |
| Lavi et al. | Conditioning of the heart: from pharmacological interventions to local and remote protection: possible implications for clinical practice | |
| Ristalli et al. | Intravascular lithotripsy and Impella support to assist complex LM angioplasty | |
| Blum et al. | Endovascular management of acute deep vein thrombosis | |
| Amemiya et al. | Usefulness of oral Xa inhibitor for management of ischemic stroke associated with thrombosis in the pulmonary vein stump after lung resection | |
| AU655780B2 (en) | A method and composition for the protection of a metabolic recovery of ischemic cardiac tissue | |
| Pierot et al. | Teaching lessons by MR CLEAN | |
| Poliwoda | Treatment of chronic arterial occlusions with streptokinase | |
| Moses et al. | Do new devices add to the results of PTCA in acute myocardial infarction? | |
| Whitley et al. | Urokinase treatment preserves endothelial and smooth muscle function in experimental acute arterial thrombosis | |
| Diffin et al. | Percutaneous recanalization of peripheral arterial occlusions | |
| Silvestri et al. | Cardiovascular issues: aneurysms and pseudoaneurysms, thrombosis, atherosclerosis, and cardiac involvement | |
| Zahger et al. | Thrombolysis in the era of the randomized trials | |
| Alkawi et al. | Advances in thrombolytics and mechanical devices for treatment of acute ischemic stroke | |
| Gupta et al. | Bilateral Catheter-Directed Thrombolysis for an Acute Bilateral Pulmonary Embolism Patient with Severe Right Ventricular Strain From Intensive Care Unit to Home on Postoperative Day 1 | |
| Park et al. | Use of non-vitamin k dependent oral anticoagulant in ischemic stroke | |
| Gersh | Acute myocardial infarction. Results of the ASSENT-3 Trial | |
| Stevens et al. | Percutaneous thrombectomy with the AngioVac aspiration device: A single-center experience | |
| Blankenship et al. | Acute myocardial infarction complicating urokinase infusion for total saphenous vein graft occlusion | |
| Spratt et al. | Pulmonary transplant salvage using ultrasound-assisted thrombolysis of subacute occlusive main pulmonary artery embolus | |
| Hokimoto et al. | Initial and mid-term outcomes of pulse infusion thrombolysis using a unique pump system and stent placement for deep vein thrombosis | |
| Dziewierz et al. | Local administration of abciximab using a ClearWay RX infusion catheter in a patient with acute coronary syndrome caused by late in− stent thrombosis |